Operating Lease, Right-of-Use Asset of MADRIGAL PHARMACEUTICALS, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
MADRIGAL PHARMACEUTICALS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • MADRIGAL PHARMACEUTICALS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $5,387,000, a 114% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

MADRIGAL PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,387,000 +$2,875,000 +114% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $5,862,000 +$4,406,000 +303% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $2,110,000 +$524,000 +33% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $2,401,000 +$688,000 +40% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $2,512,000 +$676,000 +37% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $1,456,000 +$1,045,000 +254% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $1,586,000 +$933,000 +143% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $1,713,000 +$1,111,000 +185% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 $1,836,000 +$1,005,000 +121% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $411,000 -$646,000 -61% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $653,000 -$43,000 -6.2% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $602,000 -$195,000 -24% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $831,000 -$66,000 -7.4% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $1,057,000 +$60,000 +6% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $696,000 -$11,000 -1.6% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $797,000 +$12,000 +1.5% 31 Dec 2021 10-K/A 03 Mar 2023 2022 FY
Q3 2021 $897,000 +$34,000 +3.9% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $997,000 +$477,000 +92% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $707,000 +$109,000 +18% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $785,000 +$110,000 +16% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $863,000 +$112,000 +15% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $520,000 -$306,000 -37% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $598,000 -$332,000 -36% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $675,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $751,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $826,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $930,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.